Article info
PDFBenefits to participants
Paper
Why high-risk, non-expected-utility-maximising gambles can be rational and beneficial: the case of HIV cure studies
- Correspondence to Dr Lara Buchak, Department of Philosophy, UC Berkeley, Berkeley, CA 94720-2390, USA; buchak{at}berkeley.edu
Citation
Why high-risk, non-expected-utility-maximising gambles can be rational and beneficial: the case of HIV cure studies
Publication history
- Received September 29, 2015
- Revised April 23, 2016
- Accepted May 7, 2016
- First published June 30, 2016.
Online issue publication
January 25, 2017
Article Versions
- Previous version (25 January 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Patients, doctors and risk attitudes
- The potential use of decision analysis to support shared decision making in the face of uncertainty: the example of atrial fibrillation and warfarin anticoagulation
- Quality-adjusted life years
- Developing a dementia-specific preference-based quality of life measure (AD-5D) in Australia: a valuation study protocol
- Rationality of irrationality: preference catering or shaping?
- Choosing the surgical mortality threshold for high risk patients with stage Ia non-small cell lung cancer: insights from decision analysis
- Eliciting patient preferences, priorities and trade-offs for outcomes following kidney transplantation: a pilot best–worst scaling survey
- Measuring the benefits of growth hormone therapy in children: a role for preference-based approaches?
- Developing a cerebral palsy-specific preference-based measure for a six-dimensional classification system (CP-6D): protocol for a valuation study
- Utility values associated with blindness in an adult population